Disorders of Sex Development

6 treatments and conditions followed through the public trial records. Not medical advice. How a status is set

Lists the pairs whose condition is this category or one beneath it. A category is not a diagnosis and not advice.

Narrower: Adrenal Hyperplasia, Congenital 1, Sexual Infantilism 2

Treatments and conditions

Disorders of Sex Development
Treatment and conditionWhere it standsTrials
Osilodrostat for adrenal hyperplasia, congenitalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine / Topiramate Extended Release Oral Capsule [Qsymia] for sexual infantilismPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Placebo (for Syntocinon) + Oxytocin for sexual infantilismTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Proton beam radiation therapy + Surgical resection for disorders of sex developmentPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Proton beam radiation therapy + Surgical resection + PAZOPANIB + Doxorubicin + Ifosfamide for disorders of sex developmentPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Proton beam radiation therapy + Surgical resection + SELINEXOR + PAZOPANIB + Doxorubicin + Ifosfamide for disorders of sex developmentPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1

Categories are from Medical Subject Headings (MeSH), U.S. National Library of Medicine, courtesy of the U.S. National Library of Medicine: MeSH. They may not reflect the most current data available from NLM. NLM does not endorse this site.